Inventor · disambiguated record
Uwe Zangemeister-Wittke
Also filed as: ZANGEMEISTER-WITTKE UWE
6 granted patents·4 pending applications·29 citations·filing 1998–2021
80Inventor score
Top patents by PatentIndex Score
10 records- 0181US9259484B2Methods for treating cancer using an immunotoxinUNIV ZUERICH·Filed 2013·Granted Feb 16, 2016·4 cites·18 claims
- 0275US8545840B2Methods for treating cancer using an immunotoxinZANGEMEISTER-WITTKE UWE·Filed 2010·Granted Oct 1, 2013·4 cites·6 claims
- 0374US11713352B2Immunotoxin for treating cancerUNIV ZUERICH·Filed 2021·Granted Aug 1, 2023·0 cites·22 claims
- 0473US11713351B2Immunotoxin for treating cancerUNIV ZUERICH·Filed 2020·Granted Aug 1, 2023·0 cites·12 claims
- 0560US10858429B2Methods for treating cancer using an immunotoxinUNIV ZUERICH·Filed 2016·Granted Dec 8, 2020·0 cites·14 claims
- 0657US6291668B1Oligonucleotide derivativesNOVARTIS AG·Filed 1998·Granted Sep 18, 2001·21 cites·2 claims
- 0750US2009214543A1Methods for treating cancer using an immuno-toxin comprising an exotoxin a moiety having a furin cleavage site replaced with a cancer associated protease site cleaved by mmp-2 or mmp-9UNIV ZUERICH·Filed 2006·Application pending·0 cites
- 0850US2007196366A1Methods for treating cancer using an immunotoxinZANGEMEISTER-WITTKE UWE·Filed 2004·Application pending·0 cites
- 0939US2006160095A1SurvivinUNIV ZUERICH·Filed 2004·Application pending·0 cites
- 1031US2013259851A1Use of prokaryotic sphingosine-1-phosphate lyases and of sphingosine-1-phosphate lyases lacking a transmembrane domain for treating hyperproliferative and other diseasesZANGEMEISTER-WITTKE UWE·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Uwe Zangemeister-Wittke files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →